{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:16:38Z","timestamp":1783062998074,"version":"3.54.6"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"research project commissioned by the National Healthcare Security Administration","award":["202534"],"award-info":[{"award-number":["202534"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024ZD0522305"],"award-info":[{"award-number":["2024ZD0522305"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"DOI":"10.1038\/s41533-026-00519-0","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:08:34Z","timestamp":1777392514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhaled corticosteroid overuse and deprescribing eligibility in COPD (iCODEC Study): a nationwide cross-sectional analysis in China"],"prefix":"10.1038","volume":"36","author":[{"given":"Changcheng","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nengming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"519_CR1","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0140-6736(18)30841-9","volume":"391","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 391, 1706\u20131717 (2018).","journal-title":"Lancet"},{"key":"519_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-001698","volume":"10","author":"M Li","year":"2023","unstructured":"Li, M. et al. Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. BMJ Open Respir. Res. 10, e001698 (2023).","journal-title":"BMJ Open Respir. Res."},{"key":"519_CR3","doi-asserted-by":"publisher","first-page":"e1183","DOI":"10.1016\/S2214-109X(23)00217-6","volume":"11","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study. Lancet Glob. Health 11, e1183\u2013e1193 (2023).","journal-title":"Lancet Glob. Health"},{"key":"519_CR4","unstructured":"National Health Commission of the People\u2019s Republic of China. Notice on the implementation of national basic public health services in 2024. https:\/\/www.nhc.gov.cn\/jws\/c100073\/202409\/3d79246ab59a4cd9a58ad155c9d87bb6.shtml Published 13 September 2024. Accessed 8 December 2025."},{"key":"519_CR5","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis, and management of COPD: 2026 report https:\/\/goldcopd.org\/2026-gold-report-and-pocket-guide\/ Published 2025. Accessed 8 December 2025."},{"key":"519_CR6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1513\/AnnalsATS.202009-1128OC","volume":"18","author":"KI Duan","year":"2021","unstructured":"Duan, K. I. et al. Low-value inhaled corticosteroids in chronic obstructive pulmonary disease and the association with healthcare utilization and costs. Ann. Am. Thorac. Soc. 18, 989\u2013996 (2021).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"519_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41533-017-0040-z","volume":"27","author":"JD Chalmers","year":"2017","unstructured":"Chalmers, J. D., Tebboth, A., Gayle, A., Ternouth, A. & Ramscar, N. Determinants of initial inhaled corticosteroid use in patients with GOLD A\/B COPD: a retrospective study of UK general practice. NPJ Prim. Care Respir. Med. 27, 43 (2017).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"519_CR8","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.2147\/COPD.S274024","volume":"15","author":"Y Zeng","year":"2020","unstructured":"Zeng, Y. et al. Current status of the treatment of COPD in China: a multicenter prospective observational study. Int. J. Chron. Obstruct. Pulmon. Dis. 15, 3227\u20133237 (2020).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"519_CR9","doi-asserted-by":"publisher","first-page":"691621","DOI":"10.3389\/fphar.2021.691621","volume":"12","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. Inhaled corticosteroids and the pneumonia risk in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials. Front. Pharmacol. 12, 691621 (2021).","journal-title":"Front. Pharmacol."},{"key":"519_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1159\/000525980","volume":"101","author":"Y You","year":"2022","unstructured":"You, Y., Ni, Y. & Shi, G. Inhaled corticosteroids and mycobacterial infection in patients with chronic airway diseases: a systematic review and meta-analysis. Respiration 101, 970\u2013980 (2022).","journal-title":"Respiration"},{"key":"519_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1370\/afm.240030","volume":"23","author":"WD Pace","year":"2025","unstructured":"Pace, W. D., Callen, E., Gaona-Villarreal, G., Shaikh, A. & Yawn, B. P. Adverse outcomes associated with inhaled corticosteroid use in individuals with chronic obstructive pulmonary disease. Ann. Fam. Med. 23, 127\u2013135 (2025).","journal-title":"Ann. Fam. Med."},{"key":"519_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve, E., Gnjidic, D., Long, J. & Hilmer, S. A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice. Br. J. Clin. Pharmacol. 80, 1254\u20131268 (2015).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"519_CR13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/thx.2004.034280","volume":"60","author":"EF Wouters","year":"2005","unstructured":"Wouters, E. F. et al. Withdrawal of fluticasone propionate from combined salmeterol\/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. Thorax 60, 480\u2013487 (2005).","journal-title":"Thorax"},{"key":"519_CR14","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa1407154","volume":"371","author":"H Magnussen","year":"2014","unstructured":"Magnussen, H. et al. Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N. Engl. J. Med. 371, 1285\u20131294 (2014).","journal-title":"N. Engl. J. Med."},{"key":"519_CR15","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1183\/09031936.00126814","volume":"44","author":"A Rossi","year":"2014","unstructured":"Rossi, A. et al. INSTEAD: a randomised switch trial of indacaterol versus salmeterol\/fluticasone in moderate COPD. Eur. Respir. J. 44, 1548\u20131556 (2014).","journal-title":"Eur. Respir. J."},{"key":"519_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1164\/rccm.201803-0405OC","volume":"198","author":"KR Chapman","year":"2018","unstructured":"Chapman, K. R. et al. Long-term triple therapy de-escalation to indacaterol\/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind, triple-dummy clinical trial. Am. J. Respir. Crit. Care Med. 198, 329\u2013339 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"519_CR17","doi-asserted-by":"publisher","first-page":"2000351","DOI":"10.1183\/13993003.00351-2020","volume":"55","author":"JD Chalmers","year":"2020","unstructured":"Chalmers, J. D. et al. Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline. Eur. Respir. J. 55, 2000351 (2020).","journal-title":"Eur. Respir. J."},{"key":"519_CR18","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1164\/rccm.202003-0625ST","volume":"201","author":"L Nici","year":"2020","unstructured":"Nici, L. et al. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am. J. Respir. Crit. Care Med. 201, e56\u2013e69 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"519_CR19","unstructured":"Chinese Pharmaceutical Association. Specifications on cough and wheeze pharmaceutical care clinic construction. http:\/\/www.cpa.org.cn\/?do=info&cid=76795 Published 29 November 2024. Accessed 8 December 2025."},{"key":"519_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.arbres.2024.03.029","volume":"60","author":"X Wu","year":"2024","unstructured":"Wu, X. et al. Clinical characteristics and 2-year outcomes of chronic obstructive pulmonary disease patients with high blood eosinophil counts: a population-based prospective cohort study in China. Arch. Bronconeumol 60, 402\u2013409 (2024).","journal-title":"Arch. Bronconeumol"},{"key":"519_CR21","unstructured":"National Bureau of Statistics of China. China statistical yearbook 2024. https:\/\/www.stats.gov.cn\/sj\/ndsj\/2024\/indexeh.htm Accessed 8 December 2025."},{"key":"519_CR22","unstructured":"National Health Commission of the People\u2019s Republic of China. Hospital classification query system. https:\/\/zgcx.nhc.gov.cn Accessed 8 December 2025."},{"key":"519_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41533-023-00347-6","volume":"33","author":"JK Quint","year":"2023","unstructured":"Quint, J. K., Ariel, A. & Barnes, P. J. Rational use of inhaled corticosteroids for the treatment of COPD. NPJ Prim. Care Respir. Med. 33, 27 (2023).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"519_CR24","doi-asserted-by":"publisher","first-page":"175346662311582","DOI":"10.1177\/17534666231158283","volume":"17","author":"T Yang","year":"2023","unstructured":"Yang, T. et al. Treatment patterns in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL). Ther. Adv. Respir. Dis. 17, 17534666231158283 (2023).","journal-title":"Ther. Adv. Respir. Dis."},{"key":"519_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/20523211.2025.2466215","volume":"18","author":"W Li","year":"2025","unstructured":"Li, W. et al. Access to single-inhaler triple medicines for chronic obstructive pulmonary disease in China: a national survey on accessibility and utilisation. J. Pharm. Policy Pract. 18, 2466215 (2025).","journal-title":"J. Pharm. Policy Pract."},{"key":"519_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-001964","volume":"11","author":"D Vauterin","year":"2024","unstructured":"Vauterin, D., Van Vaerenbergh, F., Grymonprez, M., Vanoverschelde, A. & Lahousse, L. Medication adherence to inhalation therapy and the risk of COPD exacerbations: a systematic review with meta-analysis. BMJ Open Respir. Res. 11, e001964 (2024).","journal-title":"BMJ Open Respir. Res."},{"key":"519_CR27","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2147\/COPD.S300299","volume":"16","author":"K Larsson","year":"2021","unstructured":"Larsson, K., Ekberg-Jansson, A., Stridsman, C., Hanno, M. & Vanfleteren, L. E. G. W. Adherence to treatment recommendations for chronic obstructive pulmonary disease - results from the Swedish National Airway Register. Int. J. Chron. Obstruct. Pulmon. Dis. 16, 909\u2013918 (2021).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"519_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/COPD.S122013","volume":"12","author":"JC Simeone","year":"2016","unstructured":"Simeone, J. C. et al. Initiation of triple therapy maintenance treatment among patients with COPD in the US. Int. J. Chron. Obstruct. Pulmon. Dis. 12, 73\u201383 (2016).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"519_CR29","doi-asserted-by":"publisher","first-page":"00123","DOI":"10.1183\/23120541.00123-2025","volume":"11","author":"Y Yin","year":"2025","unstructured":"Yin, Y. et al. Guideline-concordant inhaled medication use in COPD: a systematic review of definitions used in administrative health data. ERJ Open Res 11, 00123\u201302025 (2025).","journal-title":"ERJ Open Res"},{"key":"519_CR30","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.2147\/COPD.S218747","volume":"14","author":"J Sulku","year":"2019","unstructured":"Sulku, J. et al. A cross-sectional study assessing appropriateness of inhaled corticosteroid treatment in primary and secondary care patients with COPD in Sweden. Int. J. Chron. Obstruct. Pulmon. Dis. 14, 2451\u20132460 (2019).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"519_CR31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1513\/AnnalsATS.201911-854OC","volume":"17","author":"LJ Spece","year":"2020","unstructured":"Spece, L. J. et al. Initiating low-value inhaled corticosteroids in an inception cohort with chronic obstructive pulmonary disease. Ann. Am. Thorac. Soc. 17, 589\u2013595 (2020).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"519_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.chest.2019.04.107","volume":"156","author":"D Stolz","year":"2019","unstructured":"Stolz, D. et al. Differences in COPD exacerbation risk between women and men: analysis from the UK clinical practice research datalink data. Chest 156, 674\u2013684 (2019).","journal-title":"Chest"},{"key":"519_CR33","doi-asserted-by":"publisher","first-page":"106105","DOI":"10.1016\/j.rmed.2020.106105","volume":"171","author":"TA Perez","year":"2020","unstructured":"Perez, T. A. et al. Sex differences between women and men with COPD: a new analysis of the 3CIA study. Respir. Med. 171, 106105 (2020).","journal-title":"Respir. Med."},{"key":"519_CR34","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00198-009-0925-y","volume":"20","author":"Y Wang","year":"2009","unstructured":"Wang, Y., Tao, Y., Hyman, M. E., Li, J. & Chen, Y. Osteoporosis in China. Osteoporos. Int. 20, 1651\u20131662 (2009).","journal-title":"Osteoporos. Int."},{"key":"519_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018404","volume":"8","author":"P Hanlon","year":"2018","unstructured":"Hanlon, P. et al. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study. BMJ Open 8, e018404 (2018).","journal-title":"BMJ Open"},{"key":"519_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/2001-1326-1-13","volume":"1","author":"X Fang","year":"2012","unstructured":"Fang, X., Li, S., Gao, L., Zhao, N., Wang, X. & Bai, C. A short-term educational program improved physicians\u2019 adherence to guidelines for COPD and asthma in Shanghai. Clin. Transl. Med. 1, 13 (2012).","journal-title":"Clin. Transl. Med."},{"key":"519_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41533-025-00448-4","volume":"35","author":"L van den Bemt","year":"2025","unstructured":"van den Bemt, L. et al. De-implementation of inappropriate inhaled corticosteroid use in patients with COPD in general practice, results of a mixed methods study. NPJ Prim. Care. Respir. Med. 35, 44 (2025).","journal-title":"NPJ Prim. Care. Respir. Med."},{"key":"519_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-07498-1","volume":"22","author":"DC Lee","year":"2022","unstructured":"Lee, D. C., Wang, J., Shi, L., Wu, C. & Sun, G. Health insurance coverage and access to care in China. BMC Health Serv. Res. 22, 140 (2022).","journal-title":"BMC Health Serv. Res."},{"key":"519_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-80989-9","volume":"14","author":"X Hu","year":"2024","unstructured":"Hu, X. et al. Physicians and hospital pharmacists\u2019 knowledge, attitudes, and practices towards polypharmacy in older patients with chronic diseases. Sci. Rep. 14, 29885 (2024).","journal-title":"Sci. Rep."},{"key":"519_CR40","first-page":"1117","volume":"36","author":"T Zheng","year":"2025","unstructured":"Zheng, T. et al. Investigation on the current status of pharmaceutical care in medical institutions in China. China Pharmacy 36, 1117\u20131122 (2025).","journal-title":"China Pharmacy"},{"key":"519_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41533-025-00413-1","volume":"35","author":"D Du","year":"2025","unstructured":"Du, D. et al. The availability of drugs for stable COPD treatment in China: a cross-sectional survey. NPJ Prim. Care Respir. Med. 35, 6 (2025).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"519_CR42","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.chest.2021.05.067","volume":"160","author":"AS Gershon","year":"2021","unstructured":"Gershon, A. S. et al. Factors associated with nonreceipt of recommended COPD medications: a population study. Chest 160, 1670\u20131680 (2021).","journal-title":"Chest"},{"key":"519_CR43","first-page":"1951","volume":"10","author":"YF Wei","year":"2015","unstructured":"Wei, Y. F. et al. Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD - subgroup analysis of the Taiwan obstructive lung disease cohort. Int. J. Chron. Obstruct. Pulmon. Dis. 10, 1951\u20131956 (2015).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00519-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:28:14Z","timestamp":1783060094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00519-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1038\/s41533-026-00519-0","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}